Friday - December 27, 2024

Nonselective Metabotropic Glutamate Receptor Activators for Treatment of Attention Deficit Disorder and 22Q Syndrome

2024-10-22

ALEXANDRIA, Virginia, Oct. 22 -- Two inventors, Hakon Hakonarson, Malvern, Pennsylvania, and Charlly Kao, Philadelphia, Pennsylvania, have been awarded a patent (No. US 12121514 B2, initially filed Dec. 17, 2020) for "Nonselective metabotropic glutamate receptor activators for treatment of attention deficit disorder and 22Q syndrome." . . .

Information Request Form

Name:
Category that best fits the type of business or agency you are affiliated with:	Government Newspaper / Media Business Public Policy Individual / Student Educators
Company Name:
Email:
Phone:
State:

I'd like to have a copy of this article mailed to me.

To also receive a free sample of other Targeted News products check the appropriate boxes below.
Golf Handicap site (FairwayFiles.com)
Products marked with ** can be customized by keywords or areas of interest. If you select them please specify your keywords in the box below:

If we need to contact you please specify your preferred contact method. Have a representative contact me by phone
Have a representative contact me via email

Additonal questions or comments:

Click here for more information or a free trial

Existing Customer Login

Nonselective Metabotropic Glutamate Receptor Activators for Treatment of Attention Deficit Disorder and 22Q Syndrome

Information Request Form

Copyright Targeted News Service 2024